April 25th 2024
A recent survey covered topics including skin-aging prevention, care-seeking behavior, trust in professionals, and more.
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
The evolution of cosmetic surgery for the common good
February 1st 2002There exists today with both the lay public and some physicians a significantmisunderstanding about who is qualified to perform cosmetic or aestheticsurgical procedures. Perhaps this is the proper time to try and correctsome of the more common misimpressions about this controversy.
Skin substitute may improve post-Mohs appearance
February 1st 2002Chicago - A single application of tissue-engineered, bilayeredskin substitute (Human Skin Substitute, Apligraf) to full-thickness woundscreated from Mohs micrographic or excisional surgery treatment of skin cancersresults in scars slightly more favorable than those healed by secondary-intentionhealing, according to single center study results.